Format
Sort by
Items per page

Send to

Choose Destination

Links from HomoloGene

Items: 1 to 20 of 907

1.

Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.

Herman JM, Fan KY, Wild AT, Wood LD, Blackford AL, Donehower RC, Hidalgo M, Schulick RD, Edil BH, Choti MA, Hruban RH, Pawlik TM, Cameron JL, Laheru DA, Iacobuzio-Donahue CA, Wolfgang CL.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):458-9. doi: 10.1016/j.ijrobp.2013.06.2039. No abstract available.

2.

Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.

Itatani Y, Kawada K, Fujishita T, Kakizaki F, Hirai H, Matsumoto T, Iwamoto M, Inamoto S, Hatano E, Hasegawa S, Maekawa T, Uemoto S, Sakai Y, Taketo MM.

Gastroenterology. 2013 Nov;145(5):1064-1075.e11. doi: 10.1053/j.gastro.2013.07.033. Epub 2013 Jul 25.

PMID:
23891973
3.

L1-ORF1p, a Smad4 interaction protein, promotes proliferation of HepG2 cells and tumorigenesis in mice.

Zhu Y, Feng F, Yu J, Song B, Hu M, Gao X, Wang Y, Zhang Q.

DNA Cell Biol. 2013 Sep;32(9):531-40. doi: 10.1089/dna.2013.2097. Epub 2013 Jul 17.

PMID:
23863096
4.

The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.

Xia RH, Song XM, Wang XJ, Li J, Mao L.

PLoS One. 2013 Jun 24;8(6):e66794. doi: 10.1371/journal.pone.0066794. Print 2013.

5.

Dual requirement of ectodermal Smad4 during AER formation and termination of feedback signaling in mouse limb buds.

Benazet JD, Zeller R.

Genesis. 2013 Sep;51(9):660-6. doi: 10.1002/dvg.22412. Epub 2013 Jul 16.

PMID:
23818325
6.

Selective Smad4 knockout in ovarian preovulatory follicles results in multiple defects in ovulation.

Yu C, Zhang YL, Fan HY.

Mol Endocrinol. 2013 Jun;27(6):966-78. doi: 10.1210/me.2012-1364. Epub 2013 Apr 16.

7.

Effects of the Smad4 C324Y mutation on thyroid cell proliferation.

D'Inzeo S, Nicolussi A, Nardi F, Coppa A.

Int J Oncol. 2013 Jun;42(6):1890-6. doi: 10.3892/ijo.2013.1908. Epub 2013 Apr 17.

8.

Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression.

Winter JM, Tang LH, Klimstra DS, Liu W, Linkov I, Brennan MF, DʼAngelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Oʼreilly EM, Allen PJ.

Ann Surg. 2013 Aug;258(2):331-5. doi: 10.1097/SLA.0b013e31827fe9ce.

9.

Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations.

Teekakirikul P, Milewicz DM, Miller DT, Lacro RV, Regalado ES, Rosales AM, Ryan DP, Toler TL, Lin AE.

Am J Med Genet A. 2013 Jan;161A(1):185-91. doi: 10.1002/ajmg.a.35659. Epub 2012 Dec 13.

10.

MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by targeting SMAD4.

Wang Y, Li W, Zang X, Chen N, Liu T, Tsonis PA, Huang Y.

Invest Ophthalmol Vis Sci. 2013 Jan 14;54(1):323-32. doi: 10.1167/iovs.12-10904.

PMID:
23221074
11.

Nimesulide inhibits the proliferation of HepG2 by up-regulation of Smad4.

Yang S, Guo R, Huang L, Yang L, Jiang D.

Indian J Pharmacol. 2012 Sep-Oct;44(5):599-601. doi: 10.4103/0253-7613.100384.

12.

SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice.

Szigeti R, Pangas SA, Nagy-Szakal D, Dowd SE, Shulman RJ, Olive AP, Popek EJ, Finegold MJ, Kellermayer R.

Ann Clin Lab Sci. 2012 Fall;42(4):401-8.

13.

Human hematopoietic stem/progenitor cells overexpressing Smad4 exhibit impaired reconstitution potential in vivo.

Rörby E, Hägerström MN, Blank U, Karlsson G, Karlsson S.

Blood. 2012 Nov 22;120(22):4343-51. doi: 10.1182/blood-2012-02-408658. Epub 2012 Sep 27.

14.

SMAD4-dependent polysome RNA recruitment in human pancreatic cancer cells.

Thornley JA, Trask HW, Ringelberg CS, Ridley CJ, Wang S, Sal-Lari RC, Moore JH, Korc M, Tomlinson CR.

Mol Carcinog. 2012 Oct;51(10):771-82. doi: 10.1002/mc.20845. Epub 2011 Aug 30.

15.

[Histological changes of peripheral vestibular organs in the inner ears of Smad4 conditional knockout mice].

Deng AC, Yang SM, Huang DL, Sun JH, Yang X.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Jul;47(7):575-80. Chinese.

PMID:
22932243
16.

Vascular smooth muscle cell Smad4 gene is important for mouse vascular development.

Mao X, Debenedittis P, Sun Y, Chen J, Yuan K, Jiao K, Chen Y.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2171-7. doi: 10.1161/ATVBAHA.112.253872. Epub 2012 Jul 5.

17.

Smad4 disruption accelerates keratinocyte reepithelialization in murine cutaneous wound repair.

Yang L, Li W, Wang S, Wang L, Li Y, Yang X, Peng R.

Histochem Cell Biol. 2012 Oct;138(4):573-82. doi: 10.1007/s00418-012-0974-8. Epub 2012 May 30.

PMID:
22644379
18.

Manifestations of juvenile polyposis syndrome in SMAD4 mutation carriers of a kindred.

Schwetz V, Uhrig S, Spuller E, Deutschmann A, Högenauer C.

Eur J Gastroenterol Hepatol. 2012 Aug;24(8):988-94. doi: 10.1097/MEG.0b013e328354f43e.

PMID:
22617360
19.

Mutations of SMAD4 account for both LAPS and Myhre syndromes.

Lindor NM, Gunawardena SR, Thibodeau SN.

Am J Med Genet A. 2012 Jun;158A(6):1520-1. doi: 10.1002/ajmg.a.35374. Epub 2012 May 14. No abstract available.

PMID:
22585601
20.

Supplemental Content

Support Center